Global Industry Growth Boosting Factors:
# Rising Prevalence of Chronic Diseases and Growing Number of Trauma and Injury Cases
# Increasing Demand for Source Plasma From Biopharmaceutical Companies
# Rising Demand for Blood Components and Growing Concerns Regarding Blood Safety
# Increase in the Number of Complex Surgical Procedures
# Favorable Reimbursement for Apheresis Procedures
The blood collection centers and blood component providers segment accounted for the largest share of the market
Based on end users, the apheresis market is segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. In 2018, the blood collection centers and blood component providers segment accounted for the largest share of 67.5% of the global apheresis market. The large share of this end-user segment is mainly attributed to the rising number of blood component donations, a growing number of blood centers, and increasing awareness of blood collection.
Expected Growth Rate:
The global apheresis market is expected to be growing at a healthy rate of 8.1% during the forecast period.
Major Objectives of This Study:
# To define, describe, and forecast the global apheresis market by product, technology, application, procedure, end user, and region.
# To provide detailed information about the factors influencing the market growth (drivers, restraints, opportunities, and challenges).
# To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market.
# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
# To forecast the size of the apheresis market in five regions (along with major countries)—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa.
# To profile key players in the apheresis market and comprehensively analyze their core competencies and market shares.
# To track and analyze competitive developments such as acquisitions; new product launches; collaborations, partnerships, and agreements; and R&D activities of the leading players in the global apheresis market.
Geographical Growth Dynamics:
North America accounted for the largest share of the apheresis market in 2018
The apheresis market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the apheresis market. The large share of this region can be attributed to easier access to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.
Key Developments, Globally:
# In July 2019, Baxter International Inc. (US) launched the PrisMax system in the US.
# In June 2019, Toray Medical Co. Ltd. (Japan) launched the TORAMYXIN device in the European region.
# In October 2019, Terumo BCT (US) collaborated with the UniCAR-Therapy Bio-Medicine Technology Co. (China). This collaboration aimed at advancing CAR T-cell therapies by creating a new Shanghai Center of Excellence. This development also helped Terumo widen its applications of apheresis and leukapheresis procedures.
# In August 2017, Fresenius Medical Care (Germany) acquired NxStage Medical, Inc. (US). This acquisition enabled Fresenius Medical Care to further expand its presence in the renal care and critical care area.
Comments are closed for this blog post